Tag Archives: non metastatic prostate cancer

Combination of Abiraterone and Prednisolone Plus Androgen Deprivation Therapy Demonstrated Improved Survival Outcomes for Patients with Nonmetastatic High-Risk Prostate Cancer

According to the findings from a combined assessment of the multistage trial named STAMPEDE presented during the 2021 European Society […]

September 21, 2021